Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma. (nejm.org)

Authors: Frigault MJ … Bishop MR Journal: New England Journal of Medicine Published: 2026-09-24 DOI: https://doi.org/10.1056/NEJMoa2603527